Determination of absolute stereochemistry, total synthesis, and evaluation of peptides from the myxomycete Physarum melleum

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 1, 2008, Pages 95-98

  Hanazawa, Shuwa ^a   Arai, Midori A ^a   Li, Xiaofan ^a   Ishibashi, Masami ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Melleumin; Myxomycete; Peptide; Physarum melleum; Wnt signal inhibitor

Indexed keywords

10 EPI MELLEUMIN B; MELLEUMIN A; MELLEUMIN B; NATURAL PRODUCT; PEPTIDE; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; EPIMER; MYXOMYCETES; NONHUMAN; PEPTIDE SYNTHESIS; PHYSARUM; PHYSARUM MELLEUM; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHYSARUM; PROTEIN CONFORMATION; PROTOZOAN PROTEINS; SIGNAL TRANSDUCTION; STEREOISOMERISM; WNT PROTEINS;

PHYSARUM MELLEUM;

EID: 37549039089     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.11.005     Document Type: Article

References (18)

1. Nakatani S., Kamata K., Sato M., Onuki H., Hirota H., Matsumoto J., and Ishibashi M. Tetrahedron Lett. 46 (2005) 267
2. Kamata K., Suetsugu T., Yamamoto Y., Hayashi M., Komiyama K., and Ishibashi M. J. Nat. Prod. 69 (2006) 1252
3. Hosoya T., Yamamoto Y., Uehara Y., Hayashi M., Komiyama K., and Ishibashi M. Bioorg. Med. Chem. Lett. 15 (2005) 2776
4. Wolf C., Francis C.J., Hawes P.A., and Shah M. Tetrahedron: Asymmetry 13 (2002) 1733
5. Rich D.H., Sun E.T., and Boparai A.S. J. Org. Chem. 43 (1978) 3624
6. Rich D.H., Sun E.T.O., and Ulm E. J. Med. Chem. 23 (1980) 27
7. McConnell R.M., Frizzell D., Camp A., Evans A., Jones W., and Cagle C. J. Med. Chem. 34 (1991) 2298
8. Ohtani I., Kusumi T., Kashman Y., and Kakisawa H. J. Am. Chem. Soc. 113 (1991) 4092
9. The condition of hydrolysis of 2; Compound 2 (0.9 mg) was treated with 6 N HCl (1.5 mL) and heated at 110 °C for 12 h (also see Ref. 1).
10. Akiyama K., Yamamoto S., Fujimoto H., and Ishibashi M. Tetrahedron 61 (2005) 1827
11. Pearson A.J., and Cui S. Tetrahedron Lett. 46 (2005) 2639
12. Corey E.J., Cho H., Rücker C., and Hua D.H. Tetrahedron Lett. 22 (1981) 3455
13. Reddy L.R., Saravanan P., and Corey E.J. J. Am. Chem. Soc. 126 (2004) 6230
14. HPLC condition: Develosil ODS-HG-5; 10 × 250 mm; eluent, 50% MeOH; flow rate, 2.4 mL/min; detection, UV at 254 nm. Retention time: 2 (14.3 min), 19 (16.0 min).
15. HPLC condition: Develosil ODS-HG-5; 20 × 250 mm; eluent, 50% MeOH; flow rate, 5.0 mL/min; detection, UV at 275 nm. Retention time: 2 (24.0 min), 19 (27.0 min).
16. Kaniwa K., Arai M.A., Li X., and Ishibashi M. Bioorg. Med. Chem. Lett. 17 (2007) 4254
17. Korinek V., Barker N., Morin P.J., and van Wichen D. Science 275 (1997) 1784
18. Xu Q., Wang Y., Dabdoub A., Smallwood P.M., Williams J., Woods C., Kelley M.W., Jiang L., Tasman W., Zhang K., and Nathans J. Cell 116 (2004) 883